These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19590498)

  • 1. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease.
    Duron E; Rigaud AS; Dubail D; Mehrabian S; Latour F; Seux ML; Hanon O
    Am J Hypertens; 2009 Sep; 22(9):1020-4. PubMed ID: 19590498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
    Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
    Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?
    Mossello E; Boncinelli M; Caleri V; Cavallini MC; Palermo E; Di Bari M; Tilli S; Sarcone E; Simoni D; Biagini CA; Masotti G; Marchionni N
    Dement Geriatr Cogn Disord; 2008; 25(4):372-9. PubMed ID: 18354253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease.
    Rockwood K; Fay S; Gorman M
    Int J Geriatr Psychiatry; 2010 Feb; 25(2):191-201. PubMed ID: 19548273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.
    Tu MC; Huang CW; Chen NC; Chang WN; Lui CC; Chen CF; Chen C; Wang YL; Lin YT; Chang CC
    Acta Neurol Taiwan; 2010 Sep; 19(3):168-77. PubMed ID: 20824536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review].
    Strnad J; Bahro M
    Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539
    [No Abstract]   [Full Text] [Related]  

  • 11. The predictive value of memory strategies for Alzheimer's disease in subjects with mild cognitive impairment.
    Ramakers IH; Visser PJ; Aalten P; Maes HL; Lansdaal HG; Meijs CJ; Jolles J; Verhey FR
    Arch Clin Neuropsychol; 2010 Feb; 25(1):71-7. PubMed ID: 19955096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease.
    Silvestrini M; Gobbi B; Pasqualetti P; Bartolini M; Baruffaldi R; Lanciotti C; Cerqua R; Altamura C; Provinciali L; Vernieri F
    Neurobiol Aging; 2009 Aug; 30(8):1177-83. PubMed ID: 18077061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive medications influence the rate of conversion from mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Trabucchi M; Padovani A
    Arch Neurol; 2008 Jul; 65(7):993-4; author reply 994-5. PubMed ID: 18625880
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cholinesterase inhibitors appear greater in patients on established antihypertensive therapy.
    Rozzini L; Vicini Chilovi B; Bellelli G; Bertoletti E; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):547-51. PubMed ID: 15920713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overgenerality of autobiographical memory in people with amnestic mild cognitive impairment and early Alzheimer's disease.
    Donix M; Brons C; Jurjanz L; Poettrich K; Winiecki P; Holthoff VA
    Arch Clin Neuropsychol; 2010 Feb; 25(1):22-7. PubMed ID: 19955095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of cognitive change in Alzheimer disease: observations across a decade of placebo-controlled clinical trials with donepezil.
    Jones RW; Schwam E; Wilkinson D; Waldemar G; Feldman HH; Zhang R; Albert K; Schindler R
    Alzheimer Dis Assoc Disord; 2009; 23(4):357-64. PubMed ID: 19561444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine's effect on neural and cognitive functioning in an aging population.
    Murray KN; Abeles N
    Aging Ment Health; 2002 May; 6(2):129-38. PubMed ID: 12028881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
    Hanyu H; Sato T; Kiuchi A; Sakurai H; Iwamoto T
    J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
    [No Abstract]   [Full Text] [Related]  

  • 20. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.